Prolotherapy for AC Joint Separation: How It Works In the context of AC joint separation, prolotherapy targets the damaged acromioclavicular and coracoclavicular ligaments , which are essential for maintaining clavicle stability
Direct Peptides BPC-157 Peptide Vial is a lyophilized powder that comes in a sterile glass vial for stability and safety
These figures are provided for research reference only and do not constitute dosing recommendations
Dihexa is a synthetic hexapeptide that binds to the c-Met receptor (hepatocyte growth factor receptor) and amplifies endogenous HGF signaling, potentiating BDNF-TrkB pathway activity by stabilizing receptor-ligand interactions with binding affinity 10,000,000 times greater than natural ligands
No TUEs, No Exceptions Unlike corticosteroids or hormone therapies that may qualify for a Therapeutic Use Exemption (TUE), BPC-157 has no approved medical use , so theres no path to exemption